These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10670038)

  • 1. [Highlights of rheumatology 1999: new developments between immunology and pain of movement mechanisms].
    Frey D; Tyndall A
    Schweiz Med Wochenschr; 2000 Jan; 130(1-2):8-13. PubMed ID: 10670038
    [No Abstract]   [Full Text] [Related]  

  • 2. Rheumatoid arthritis.
    Ramsburg KL
    Am J Nurs; 2000 Nov; 100(11):40-3. PubMed ID: 11103634
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rheumatoid arthritis in adult: beginning the management in 3 months].
    Lioté F
    Rev Prat; 2005 Dec; 55(19):2103-5. PubMed ID: 16544920
    [No Abstract]   [Full Text] [Related]  

  • 4. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years).
    Luqmani R; Hennell S; Estrach C; Basher D; Birrell F; Bosworth A; Burke F; Callaghan C; Candal-Couto J; Fokke C; Goodson N; Homer D; Jackman J; Jeffreson P; Oliver S; Reed M; Sanz L; Stableford Z; Taylor P; Todd N; Warburton L; Washbrook C; Wilkinson M; ;
    Rheumatology (Oxford); 2009 Apr; 48(4):436-9. PubMed ID: 19174570
    [No Abstract]   [Full Text] [Related]  

  • 5. The status of stem cell transplantation for rheumatoid arthritis: a rheumatologist's view.
    Furst DE
    J Rheumatol Suppl; 2001 Oct; 64():60-1. PubMed ID: 11642508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsating back pain associated with tumor necrosis factor-alpha blockade.
    Rozin AP; Braun-Moscovici Y; Balbir-Gurman A
    Ann Pharmacother; 2008 Dec; 42(12):1912-3. PubMed ID: 19033477
    [No Abstract]   [Full Text] [Related]  

  • 7. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2005 Jan; 72():46-7. PubMed ID: 15660467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F; Murdaca G; Ghio M; Indiveri F
    Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of rheumatoid arthritis.
    Handa R
    Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis.
    Dugina JL; Petrov VI; Babayeva AR; Martyushev-Poklad AV; Tcherevkova EV; Epstein OI; Sergeeva SA
    Int J Tissue React; 2005; 27(1):15-21. PubMed ID: 15847101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction. New directions in anti-inflammatory therapy and pain management.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):1-3. PubMed ID: 12528068
    [No Abstract]   [Full Text] [Related]  

  • 12. Key developments in rheumatology.
    Bacon PA; Allen M
    Practitioner; 1999 Dec; 243(1605):867-71. PubMed ID: 10790911
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of tumor necrosis factor alpha and ankylosing spondylitis.
    Marzo-Ortega H; Emery P; McGonagle D
    N Engl J Med; 2003 Jan; 348(4):359-61; author reply 359-61. PubMed ID: 12542065
    [No Abstract]   [Full Text] [Related]  

  • 14. [New drug treatments for rheumatoid arthritis].
    Nordström DC; Konttinen YT
    Duodecim; 2000; 116(11):1221-5. PubMed ID: 11989008
    [No Abstract]   [Full Text] [Related]  

  • 15. The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.
    Feldmann M; Brennan FM; Williams RO; Woody JN; Maini RN
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):59-80. PubMed ID: 15123038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C.
    Niewold TB; Gibofsky A
    Arthritis Rheum; 2006 Jul; 54(7):2335-7. PubMed ID: 16802375
    [No Abstract]   [Full Text] [Related]  

  • 17. New treatments for juvenile idiopathic arthritis.
    Hashkes PJ; Friedland O; Uziel Y
    Isr Med Assoc J; 2002 Jan; 4(1):39-43. PubMed ID: 11802310
    [No Abstract]   [Full Text] [Related]  

  • 18. [Double-blind trial of the effectiveness of antibodies to interferon-gamma and tumor necrosis factor-alpha in rheumatoid arthritis (preliminary results)].
    Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS
    Ter Arkh; 2001; 73(5):12-5. PubMed ID: 11517739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical agents for the treatment of rheumatoid arthritis.
    Scott TE
    Manag Care; 2001 Jul; 10(7 Suppl):2-9. PubMed ID: 11729431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.